Evidence map›Paper›PMID 35303530›Full record

ArticleMolecular immunology2022

Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease.

Arthur J Chang, Sarah Baron, Jonathon Hoffman, Mark D Hicar

Open access · greenAbstract read
In one paragraph

Article in Molecular immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Arthur J ChangUniversity at Buffalo, Department of Pediatrics, USA.
Sarah BaronUniversity at Buffalo, Department of Pediatrics, USA.
Jonathon HoffmanUniversity at Buffalo, Department of Pediatrics, USA.
Mark D HicarUniversity at Buffalo, Department of Pediatrics, USA. Electronic address: markhica@buffalo.edu.
University at Buffalo, State University of New York · US

Funding

The role of non-broadly neutralizing antibodies targeting gp41 structural epitopes in long term nonprogression of HIV infectionR01AI125119 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI HICAR, MARK DANIEL · 2016 to 2020
$2.0M
NIAID NIH HHS R01 AI125119
6 · The paper itself

Abstract

Kawasaki disease (KD) is the leading cause of acquired heart disease in children. The cause remains unknown; however, epidemiologic and demographic data support a single preceding infectious agent may lead to KD. A variety of pathophysiologic responses have been proposed, including direct invasion of the coronary arteries, a superantigen response, and a post-infectious autoimmune phenomenon. A role for B cell responses during KD are supported by numerous findings including B cell specific markers identified in genome wide association studies. We have recently published data showing children with KD have similar plasmablast (PB) responses to children with infections. Since during other infections, cells expressing antibodies against the preceding infection are enriched in PBs, we sought to explore the specific antibodies encoded by PBs during KD. In one child we see a massive expansion in IGHV4-34 utilizing antibodies, which has been associated with autoimmunity in the past. We further explored this expansion of IGHV4-34 utilization during the peripheral PB rise with next generation sequencing (NGS) analysis and utilizing newer techniques of chromium chip single cell separation (10x Genomics®). We also utilized peptide array screening to attempt to identify an antigen to the most prolific clones.

Indexed as

Mucocutaneous Lymph Node SyndromeAntibodiesBiomarkersB-LymphocytesChildGenome-Wide Association StudyHumansMutationPlasma CellsAntibodiesBiomarkersAntibodyAutoantibodiesDirected mutationsKawasaki disease

Identifiers

PMID35303530
PMCPMC9166636
OpenAlexW4220752306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.